Suppr超能文献

二乙基亚硝胺诱导的肝增生性结节和肝细胞癌发生过程中鸟氨酸脱羧酶活性、S-腺苷-L-甲硫氨酸和5'-甲硫基腺苷含量的变化

Variations of ornithine decarboxylase activity and S-adenosyl-L-methionine and 5'-methylthioadenosine contents during the development of diethylnitrosamine-induced liver hyperplastic nodules and hepatocellular carcinoma.

作者信息

Garcea R, Pascale R, Daino L, Frassetto S, Cozzolino P, Ruggiu M E, Vannini M G, Gaspa L, Feo F

出版信息

Carcinogenesis. 1987 May;8(5):653-8. doi: 10.1093/carcin/8.5.653.

Abstract

Liver ornithine decarboxylase (ODC) activity and content of S-adenosyl-L-methionine (SAM) and its catabolite 5'-methylthioadenosine (5'-MTA) were determined in the late stages of hepatocarcinogenesis. Wistar rats received one diethylnitrosamine dose, followed by a partial hepatectomy at the midpoint of a 15-day treatment with 2-acetylaminofluorene (2-AAF), and then by an 18-week phenobarbital (PB) treatment. Thirty-eight per cent of liver was gamma-glutamyltranspeptidase (GGT)-positive and no visible nodules and hepatocellular carcinomas developed 16 weeks after starting 2-AAF feeding. Hyperplastic nodules and hepatocellular carcinomas were found on weeks 24 and 56 respectively. On weeks 24 and 56 only approximately 10% of liver was occupied by GGT-positive foci. At all times studied the foci exhibited a low labeling index (LI), and liver ODC activity was near control values. By contrast, a high ODC activity and LI and a low SAM and 5'-MTA levels were found in hyperplastic nodules and neoplasia. These tissues exhibited a high 5'-MTA phosphorylase activity. SAM administration during PB treatment, caused a 25-36% fall of GGT-positive liver and prevented the development of hyperplastic nodules and hepatocellular carcinomas. This was coupled to a sharp increase of SAM and 5'-MTA liver contents. SAM and 5'-MTA inhibited hepatocyte DNA synthesis in vitro. The addition of 5'-MTA to the reaction mixture for the ODC assay strongly inhibited ODC activity. However, the preincubation of SAM with liver homogenates or hepatocytes, used to prepare crude ODC, was necessary to inhibit ODC activity by SAM. Adenine, an inhibitor of 5'-MTA-phosphorylase, enhanced inhibition of DNA synthesis and ODC activity by SAM and 5'-MTA. Thus, during a prolonged promoting treatment a selected population of GGT-positive foci appears to acquire a stable phenotype characterized by a high DNA and polyamine synthesis. The development of nodules and carcinomas is associated with low SAM and 5'-MTA contents and high ODC activity and LI. 5'-MTA accumulation, during SAM administration, is probably responsible for the inhibition of promotion by SAM.

摘要

在肝癌发生的晚期阶段,测定了肝脏鸟氨酸脱羧酶(ODC)活性以及S-腺苷-L-甲硫氨酸(SAM)及其分解代谢产物5'-甲硫基腺苷(5'-MTA)的含量。Wistar大鼠接受一次二乙基亚硝胺剂量,随后在15天的2-乙酰氨基芴(2-AAF)治疗中期进行部分肝切除术,然后进行18周的苯巴比妥(PB)治疗。在开始喂食2-AAF 16周后,38%的肝脏γ-谷氨酰转肽酶(GGT)呈阳性,未出现可见结节和肝细胞癌。分别在第24周和第56周发现了增生性结节和肝细胞癌。在第24周和第56周,只有约10%的肝脏被GGT阳性灶占据。在所有研究时间点,这些病灶的标记指数(LI)较低,肝脏ODC活性接近对照值。相比之下,在增生性结节和肿瘤中发现ODC活性和LI较高,而SAM和5'-MTA水平较低。这些组织表现出较高的5'-MTA磷酸化酶活性。在PB治疗期间给予SAM,导致GGT阳性肝脏减少25%-36%,并阻止了增生性结节和肝细胞癌的发生。这与肝脏中SAM和5'-MTA含量的急剧增加相关。SAM和5'-MTA在体外抑制肝细胞DNA合成。在ODC测定反应混合物中加入5'-MTA强烈抑制ODC活性。然而,SAM与用于制备粗ODC的肝脏匀浆或肝细胞预孵育,对于SAM抑制ODC活性是必要的。腺嘌呤是5'-MTA磷酸化酶的抑制剂,增强了SAM和5'-MTA对DNA合成和ODC活性的抑制作用。因此,在长期促癌治疗期间,选定的GGT阳性病灶群体似乎获得了一种以高DNA和多胺合成特征的稳定表型。结节和癌的发生与低SAM和5'-MTA含量以及高ODC活性和LI相关。在给予SAM期间出现的5'-MTA积累,可能是SAM抑制促癌作用的原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验